MYELOFIBROSIS

This adverse event was reported 2878 times

These drugs are most commonly taken by patients reporting MYELOFIBROSIS:

# Drug Count
0 RUXOLITINIB 887
1 HYDROXYUREA 264
2 ASPIRIN 162
3 ASPIRIN 325 MG 154
4 ASPIRIN 81 MG 154
5 ROMIPLOSTIM 149
6 ALLOPURINOL 146
7 FUROSEMIDE 123
8 DEFERASIROX 120
9 PREDNISONE 96
See all common drugs associated with MYELOFIBROSIS

MYELOFIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TIMOLOL HEMIHYDRATE 1 0.0769
1 MOMELOTINIB 62 0.0592
2 ANAGRELIDE HYDROCHLORIDE 39 0.0343
3 ALUMINUM CHLOROHYDRATE 1 0.0263
4 FEDRATINIB HYDROCHLORIDE 17 0.0133
5 RUXOLITINIB 887 0.0132
6 HYDROXYUREA 264 0.0129
7 DANAZOL 35 0.0129
8 ROMIPLOSTIM 149 0.0103
9 PACRITINIB 27 0.0098
See all drugs enriched for association with MYELOFIBROSIS

MYELOFIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thrombopoietin Receptor Agonist [EPC] 149 0.0103
1 Interferon alfa-2b [EPC] 13 0.0083
2 Janus Kinase Inhibitor [EPC] 890 0.0060
3 Complement Factor D Inhibitor [EPC] 1 0.0053
4 Iron Chelator [EPC] 124 0.0043
5 Erythroid Maturation Agent [EPC] 9 0.0041
6 Kinase Inhibitor [EPC] 941 0.0018
7 Xanthine Oxidase Inhibitor [EPC] 157 0.0009
8 Androgen [EPC] 40 0.0009
9 CD33-directed Immunoconjugate [EPC] 3 0.0008
See all drug classes enriched for association with MYELOFIBROSIS